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Executive Summary 
For the average patient, medical professionals typically recommend exercise to enhance 
the health of their patients in multiple ways.  Oncology patients, however, often have different 
issues that the treating physicians are more concerned about, so physical activity gets placed on 
the back burner.  The need for exercise in oncology patients is certainly a decision that should be 
part of an individualized treatment plan, but it is reasonable to believe that most of these patients 
will benefit from participating in an exercise program.  With the high demanding need to 
decrease chemotherapy side effects and improve lives of those undergoing it, this benchmark 
project will review supporting literature evidence that demonstrates a simple intervention to 
successfully make that improvement.  The PICOT question to be discussed in this paper is: In 
oncology patients (P), how does a regular exercise program (I) compared to no exercise program 
(C) affect cancer-related fatigue (O) during the first three months of treatment (T)? 
1. Rationale 
Cancer-related fatigue (CRF) has become well-known as one of the most common 
distressing symptoms experienced by oncology patients, as the ongoing physical and emotional 
exhaustion can limit one’s ability to function and his or her quality of life (NCCN, 2018).  This 
clinical issue has a significant role in healthcare due to the high prevalence rate of 50-90% in 
patients with a cancer diagnosis (Becze, 2019).  CRF remains underdiagnosed and underreported 
by patients that believe it is simply a part of the diagnosis and treatment process, thus preventing 
the treating providers from managing this symptom.  A change is warranted in nursing practice 
regarding the desperate need for knowledge on how to best manage and control the effects of 
CRF.  According to Fernandez et al. (2015), the benefits of exercise not only greatly reduce CRF 
and improve quality of life, but also extend to domains of reducing pain, increasing physical 
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performance, and improving mental health symptoms.  This debilitating symptom can be 
managed by the simple action of incorporating exercise into the patient’s daily routine.   
Without implementing this evidence-based change, maximum benefits of pharmacologic 
treatment may not be reached, the patient’s healthcare costs will likely increase, and more 
symptom related hospitalizations can be expected to occur.  Haas et al. (2016) explains that 
exercise is the sole treatment that provides a broad spectrum of benefit in cancer prevention and 
treatment with minimal side effects at the lowest cost.  With consistent exercise as a concurrent 
treatment, chemotherapy delivery to tumors is increased, healthcare costs including oxygen, 
provider visits, and hospitalizations were decreased, and survival rates increased by 
approximately 50% (Haas et al., 2016).   
2. Literature Synthesis 
The appraised literature for this evidence-based change project includes three level I 
meta-analysis and systemic review studies, six level II randomized controlled trials (RCT), and 
three level III quasi-experimental studies.  They all relevantly answer the proposed clinical 
question being discussed.  According to the evidence, an individualized exercise program should 
be considered an effective treatment for CRF reduction in oncology patients; therefore, it should 
be incorporated into the standard treatment plans and protocol. 
According to the research, exercise not only decreases CRF, but it also reduces 
depression and anxiety, increases physical performance, and improves quality of life (Mijwel et 
al., 2019; Oertle et al., 2016; Rogers et al., 2017).  With the symptoms better controlled by 
performing routine physical activity, the patient is more prone to have an increased independence 
and ability to perform activities of daily living with less assistance.  When the patient has a 
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higher level of energy and a more positive mindset, she is more likely to be successful at 
completing the cancer treatments and promoting her own self-care at home.   
Long term effects of an exercise program were studied by Mijwel et al. (2019) and 
Witlox et al. (2018) at one- and four-years post treatment, respectively.  It was found that 
compared to patients that were not physically active, those that participated in moderate or 
vigorous exercise during treatment continued to experience significantly lower CRF at their 
long-term follow up appointments (Mijwel et al., 2019; Witlox et al., 2018).  These patients also 
benefit from generally improved health and reduced financial depletion from prolonged sick 
leave (Mijwel et al., 2019).   
Findings in two of the meta-analysis studies determined that aerobic exercise, both alone 
and in combination with resistance training, had a significant affect in reducing CRF during 
chemotherapy treatments, while resistance training alone only moderately improved CRF, and no 
physical activity at all had no improvement on symptom management (Meneses-Echávez et al., 
2015; Tian et al., 2016).  These finding prove important in the change project to determine the 
best type of exercise to incorporate in the program being implemented.  The randomized 
controlled trial by Patel and Bhise (2017) provided data that demonstrated even patients who 
could only tolerate low to moderate intensity exercise experienced a significant reduction in 
CRF, better physical performance, and improved quality of life. 
 Al Maqbali et al. (2019) discusses in the systematic review how multiple studies 
discovered that physical activity has the potential to reverse the debilitating symptom of fatigue 
in gynecological cancer survivors.  This evidence demonstrates the importance of implementing 
the exercise as soon as the patient is diagnosed and beginning treatment to prevent from having 
to reverse symptoms that have already arose.  One RCT deliberated that the higher the intensity 
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of exercise early on in the diagnosis, the more improvement will be seen in physical functioning, 
quality of life, and CRF (Brown et al., 2018).   
 An RCT by Kampshoff et al. (2015) and a quasi-experimental study by Marker et al. 
(2018) went one step further than testing aerobic exercise on CRF and also investigated the 
potential impact of exercise on cardiorespiratory fitness and muscle strength.  Both studies 
demonstrated that a physical activity intervention significantly improved fatigue, 
cardiorespiratory fitness, and muscle strength (Kampshoff et al., 2015; Marker et al., 2018).  This 
improvement not only increases the quality of life of the patients, but also reduces the need for 
medical interventions, such as medications, hospitalizations, or surgeries.  Gheyasi et al. (2019) 
showed a statistical significance of p <0.001 in the reduction of CRF after just five to ten days of 
a cost-effective walking method.  All of these studies demonstrate strong evidence to support the 
implementation of exercise in oncology patients. 
3. Stakeholders 
People who are directly and indirectly effected by this intervention are the ones who will 
have the biggest impact on the development and success of the overall project.  The stakeholders 
for this benchmark project include the patient and the patient’s family members or support 
system, the oncologist or nurse practitioner provider, the nurses, medical assistants, clinic 
director, certified trainer, and the organization management.  Each of these project stakeholders 
will play a key part in the planning, implementation, evaluation, and dissemination of the 
exercise program.  The provider will play a key role in assessing the patient, working with the 
trainer to develop an individualized plan, and monitoring the progress throughout the program.  
The nurses and medical assistants will be the ones collecting essential information and assisting 
with basic needs or questions from the patient as well as coordinating a schedule.  The clinic 
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director and organization management will have an investment role to provide funding and aid in 
disseminating the project and developing a policy to include physical activity as part of a 
generalized treatment plan for all oncology patients.  The patient and family will have the largest 
role and impact by participating in all necessary sessions, answering questionnaires honestly, and 
providing their feedback regarding their experiences and suggestions. 
4. Implementation 
To ensure success for any change project, developing a plan is an essential part of the 
process.  Prior to implementation, it is essential to have an organized approach with preparation 
and planning to accomplish a successful vision (Hockenberry et al., 2015).  The overall plan for 
this program is to take willing participating patients undergoing chemotherapy treatment with a 
new diagnosis of cancer and assess them for an individualized and supervised exercise program 
in hopes that it will reduce the amount of cancer-related fatigue they experience.  After approval 
is gained from the administration and clinical director, adult patients will be recruited from 
Texas Oncology in Tyler to participate in this change project program.  It is intended for twenty 
patients to be recruited that will agree to sign an informed consent and participate in twelve 
weeks of physical activity. 
The major steps of the exercise program implementation plan include obtaining 
permission from the clinic administration, gain funding for required equipment and trainer, 
obtain equipment needed, build a selectively skilled multidisciplinary team, educate the team on 
their assigned roles, recruit patients, provide an education session for the patients regarding the 
risks and benefits, assess and individualize plans for the patient, perform a baseline questionnaire 
assessment, initiate the exercise program, perform follow up assessments, measure clinical 
outcomes, and disseminate results for future programs.  
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4.1 Step One 
 The first step in this project would be to take the proposal to the clinic administration and 
discuss with them the idea to ensure that they are interested in allowing it at the facility.  A good 
idea would be to take a printed and laminated blueprint layout of the timeline and the evaluation 
table that demonstrates the research that has been performed over this topic and the statistics that 
show the significant advantages of incorporating the exercise program into a practice.  Once 
granted permission, there would need to be a discussion with the clinical director about funding 
of the supplies and trainer.  If the clinic director is in agreeance, the funds may be allocated from 
the clinic profits and donations collected throughout the year from fundraisers.   
4.2 Step Two 
Equipment such as a treadmill, resistance bands, and dumbbells will need to be purchased 
or donated at this point to prepare for the project implementation.  The equipment that is 
gathered will be set up in a designated room at the facility.  Equipment will be cleaned with 
sanitation wipes before and after each patient’s use. 
4.3 Step Three 
 Members of a multidisciplinary team can make or break your project, so selective 
involvement is best.  Time will need to be spent prior to this point observing coworkers and 
employees to choose the strongest people in different areas that are willing to help and have the 
skills necessary for success.  The team members needed will be the team lead, trainer, clinic 
director, provider/nurse practitioner, registered nurse, medical assistant, patient, and the patient’s 
support person.   
4.4 Step Four 
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Once the team has been chosen, specific role education will need to be provided.  The 
provider role is to assess the patient for eligibility, discuss the importance of physical activity, 
review any risks, perform a baseline physical assessment, and address any questions or concerns 
from the patient or their support person.  The registered nurse role is to review the follow up 
assessment questionnaires with the patient at one week, four weeks, and twelve weeks.  The 
medical assistant will schedule the patient at their convenience for the exercise times and 
perform pre and post vital signs to ensure that they are maintaining safe levels to continue.  The 
clinic director will be responsible for granting permission and allocating funding.  The trainer 
will be responsible for ensuring patient safety during the sessions and working with the provider 
to individualize the program for each patient based on their unique abilities and needs.  The team 
leader will ensure that all team members have the supplies that are needed, answer questions, and 
perform statistical analysis to determine improvement levels based on questionnaires and 
physical functioning advancements throughout the program.  The patient and support person are 
required to come to each scheduled appointment.  The patient will participate in stretches, 
physical activity deemed appropriate by the provider and trainer, and be responsible for 
completing questionnaires honestly.   
4.5 Step Five 
 To recruit patients, each new patient with a cancer diagnosis will be given a brochure and 
informed about the program purpose.  His or her participation will be optional, and an informed 
consent will be reviewed and signed by the patient and provider prior to assessment for initiation.  
A goal of twenty patients to participate is made for recruitment purposes. 
4.6 Step Six 
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During the same week that the patients are recruited and once they have signed the 
informed consent, he or she will attend an education session with the provider to learn the 
detailed risks and benefits of the program.  At this visit, the patient will have a thorough physical 
assessment to determine baseline physical functioning.  The trainer and provider will collaborate 
and determine the individualized exercise plan for the patient based on their unique needs and 
abilities, whether it includes stretching, aerobic exercise, weight bearing exercises, resistance 
training, or a combination of those.  At this educational appointment, the RN will provide a 
questionnaire to get a baseline of the patient’s cancer-related fatigue level.   
4.7 Step Seven 
 After all of the above steps have been completed, the next step is to initiate the exercise 
program.  This program will go for twelve weeks and the patient will meet with the trainer three 
times a week on their scheduled dates and times for one hour per day.  Appointments will be 
made by the medical assistant based on the patient preference and trainer availability. 
4.8 Step Eight 
After one week, four weeks, and at the completion of the program in twelve weeks, the 
RN will administer the questionnaire to monitor changes in the patient’s cancer-related fatigue 
levels.  The questionnaire will ask questions regarding the patient’s fatigue level each day, 
whether the fatigue prevents them from doing any ADLs or IADLs, and how the fatigue has 
affected their family and social life.  It will also ask about their associated depression, anxiety, 
and physical strength capabilities.   
4.9 Step Nine 
At the completion of the twelve-week exercise program, the outcomes will be measured.  
Statistical analysis of the questionnaires with levels of cancer-related fatigue on a scale of 0-100 
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will be analyzed to monitor for a significant improvement or note any data changes.  The patients 
will reflect on any differences in emotional stability of depression and anxiety throughout the 
program.  Data from the trainer will also be evaluated to observe for increase in physical 
functioning and independence of performing ADLs and IADLs.   
4.10 Step Ten 
Once the statistical data is collected, a debriefing meeting will be held with the project 
team to discuss overall benefits and any concerns.  This debriefing period will allow discussion 
of any actions that were taken with patients throughout the twelve-week program.  It will 
encourage improvement in future performance and project implementation.  Reviewing the topic 
that was studied and the results that were evidenced throughout the project is an essential final 
step of the teamwork. 
4.11 Step Eleven 
Finally, the last step in this project is to present the outcomes to the stakeholders and 
disseminate the results for future programs.  This step will increase awareness of the change 
project and research and maximize the impact that it may have in the patients’ health outcomes.  
One of the most important steps in any research or change project is making the information 
known to a greater amount of people to expand the evidence-based practice in other settings. 
5. Timetable / Flowchart 
The following flowchart demonstrates the timeline that would have been used this 
semester to implement the exercise program project to reduce CRF in oncology patients. 
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6. Data Collection Methods / Planned Evaluation 
Evaluating the outcomes of a change project is an essential part of incorporating it into 
evidence-based practice (Brewer & Alexandrov, 2015).  For this intervention of an exercise 
program to reduce cancer-related fatigue in oncology patients, choosing the best objectives and 
outcomes to measure is a major part of portraying if the project is successful or not.  The selected 
primary outcome for this change project is the level of experienced cancer-related fatigue, while 
the secondary outcomes to be evaluated will include costs related to the implementation and 
adverse events experienced by the patients during the duration of this twelve-week program.   
For the Capstone project this semester, a benchmark project will be completed due to 
restrictions placed at most healthcare facilities by COVID-19.  In the future, however, the plan is 
to implement this project to improve oncology patients’ quality of life.  Once the exercise 
program is initiated, the next step to consider is how to gain information needed to measure the 
outcomes of this intervention.  The questionnaires to be completed by the participating patients 
are the Piper Fatigue Scale, the Fatigue System Inventory scale, and the Functional Assessment 
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of Chronic Illness Therapy scale.  At each follow up visit, the questionnaire results will be 
discussed with the patients to gain a better understanding of their perspective and experiences.  
Following completion of the program, the total scores on the surveys for each patient will be 
calculated and the increase or decrease in reported fatigue individually will be noted. 
Secondary measurable objectives will also be observed during this evaluation, including 
costs associated with the project as well as hospitalizations and rehab admissions associated with 
fatigue and decreased physical functioning abilities.  At the completion of the outcome 
measurements, a table will be created with all of the data results gathered and synthesized.  This 
table will help prepare for an outcome debriefing with management at the facility and 
dissemination for future use and incorporation into evidence-based practice.   
6.1 Step One 
 The initial step in this Capstone project evaluation is to decide on the necessary 
measurement tools.  In this situation, the chosen tools are the Piper Fatigue Scale, the Fatigue 
System Inventory scale, and the Functional Assessment of Chronic Illness Therapy scale.  These 
surveys will determine if the patients experienced any fatigue and to what extent the fatigue 
affected their daily lives including their activities of daily living, social lives, work functioning, 
and more.  According to Tian et al. (2016), the FACT-F scale is the most common measurement 
tool for cancer-related fatigue and the revised Piper Fatigue Inventory scale is more consistently 
the best validated fatigue measurement instrument.  The patients will be asked to complete these 
questionnaires at their baseline appointment, at their one week follow up, four week follow up, 
and post-completion of the exercise program at the twelve week mark.  Having these four 
different time points to evaluate will provide better insight on the improvement in the cancer-
related fatigue experienced by these patients.   
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6.2 Step Two 
 The second step of this evaluation process is to discuss the questionnaire results with the 
patients.  Clarifying survey questions and having a direct one-on-one conversation about their 
honest questionnaire answers could provide better insight into adjustments that need to be made 
or put into perspective other changes that should be considered to improve their experience and 
promote better outcomes.  This discussion should take place at each of the follow up visits after 
the patient has completed the questionnaires.   
6.3 Step Three 
 The third step in this project proposal outcome measurement is to take the questionnaire 
results from each of the four follow up visits and calculate the differences.  Each survey will 
have a total number associated with the patient’s selected responses.  That total number will be 
taken at each of the four visits to discover if it is increasing or decreasing, and by how much.  
The percentage of increase or decrease will be calculated to distinguish an overall response and 
the significance level of the intervention.  A 20% decrease or better will signify a significant 
improvement in CRF for this project purpose. 
6.4 Step Four 
 After the primary objective of decreasing cancer-related fatigue has been measured, the 
evaluation will shift to secondary objectives.  In this step, at the project completion follow up 
visit, the participating patients will be evaluated and questioned regarding the number of 
hospitalizations and rehab admissions occurring during this twelve-week intervention period 
related to fatigue or decreased physical functioning.  Part of the questionnaires also discuss falls.  
If a patient reports a fall on the questionnaire, it will be discussed with them to determine the 
number of falls and whether it was related to a lack of strength or fatigue.  This may help 
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determine to what extent the fatigue is affecting their lives and brainstorm on further ways to 
help the patients.  If the number of hospitalizations and rehab admissions have decreased, this 
will help reinforce the hopeful findings of the change project program.     
6.5 Step Five  
 Another secondary objective to measure will be costs related to the intervention.  This 
final cost evaluation will occur after the twelve-week program has been completed and all data 
can be gathered.  The cost analysis will be discussed in the next section designated for that 
purpose. 
6.6 Step Six 
 The final step to consider in evaluating the outcomes of this change project is to complete 
a table of all the data gathered throughout the program.  This table will synthesize the results and 
designate whether the patients experienced a significant increase or decrease in their cancer-
related fatigue.  After all of the evaluation steps have been completed, a debriefing meeting with 
management will occur to review the findings of the project.  This synthesis results table will 
help prove the necessity of the intervention to improve quality of life in the facility’s patients.  
Creating the table for this step will also aid in the dissemination process to incorporate the 
exercise program into future evidence-based standard practice.   
7. Cost / Benefit Discussion 
The cost of this project was analyzed by breaking down the individual expenses of the 
certified trainer, the necessary equipment, and hourly wages for staff education.  Necessary 
equipment for this project is a treadmill, resistance bands, and dumbbells, which averaged out to 
be $1500.  This cost may be reduced by accepting used and sanitized donations or using profits 
from fundraisers often hosted throughout the year.  One certified trainer for this implementation 
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has an average annual salary of $60,000.  Staff education may be provided via web training to be 
done virtual over a lunch break to reduce additional hourly wages.   
 According to an economic burden study performed by Rashid et al. (2016), over 76% of 
participating cancer patients receiving chemotherapy experienced a need for outpatient or 
inpatient treatment due to adverse events related to their treatment.  Twenty-one episodes of 
fatigue and muscle-related weakness were reported during their study, which totaled out to 
expenses equaling $80,667 (Rashid et al., 2016).  This would equal an average of $3,841 for 
each patient that is hospitalized or requires treatment for CRF side effects.  If twenty 
participating patients are each spared one hospitalization episode of side effects related to CRF, 
that would save $76,820, which would exceed the expenses necessary for the prevention 
program.  Due to the escalating costs of clinical trials, the average monthly cost of cancer drugs 
has risen to more than $10,000.  The positive impact that exercise has during cancer treatments 
has led to a reduction in health care costs by significantly reducing ER visits, 30-day readmits, 
and a shorter length of stay in hospitalized patients (Wonders et al., 2019).   
 A total annual expense of $61,500 for the certified trainer and essential equipment is far 
exceeded by the potential hospitalizations of the twenty projected study participants, necessary 
medications to reduce side effects, and wasted costs of missed chemotherapy infusions.  With 
health care and chemotherapy costs constantly rising, cancer patients are three times more likely 
than those without cancer to file for bankruptcy and be met with unrealistic financial burdens 
(Wonders et al., 2019).  Financially speaking, the low costs and abundant benefits from a simple 
exercise intervention far exceed the anticipated expenses to limit patients to treatment without 
physical activity. 
8. Overall Discussion / Results 
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Since this exercise intervention project is a benchmark, there are no official results or 
evaluations yet at this time.  The clinic director and multiple providers have expressed interest 
and positive feedback in regard to implementing this project on a future date when there are not 
so many concerns or restrictions regarding COVID-19 safety and prevention.  The budget for 
financing is being reviewed for approval of incorporating this program into the optional and 
rarely used fitness program that is already present at the facility.   
For this project to be deemed successful, at least twenty willing patients diagnosed with 
cancer must complete this twelve-week exercise program and associated CRF questionnaires.  
Successful CRF reduction will be defined as greater than a 20 percent decrease from baseline to 
week twelve in total scores from the questionnaires that are distributed.  Realistic goals for this 
project have been set so successful achievement of the expected outcomes are anticipated when 
this project is implemented into practice.  
9. Recommendations 
While physical activity should be encouraged for all patients, it is especially important to 
focus on cancer patients and their need to reduce treatment related side effects including CRF.  It 
has been found that the effects of exercise are greatly enhanced when the patient is supervised 
and the plan is individualized by the provider to tailor to his or her unique needs (Meneses-
Echávez et al., 2015).  The current standard of not discussing physical activity or CRF 
prevention with patients is not considered best practice based on the evidence.   
 In order for patients to have the most independence with activities of daily living and the 
highest quality of life, it is recommended that patients initiate exercise including supervised 
training at least three times a week for one-hour sessions during this program.  Cost effectiveness 
has been demonstrated in that this physical activity may help patients of employment age return 
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to work sooner and reduce the amount of sick days needed (Mijwel et al., 2019).  It is, therefore, 
recommenced to incorporate individualized physical activity into the treatment regimen for 
cancer patients undergoing chemotherapy.   
 When this project is able to be implemented, it is recommended that the next step after 
completion be to set a standard protocol treatment including exercise in all oncology clinics.  
Patients, leaders, and healthcare staff will need to work together as a team to move mountains 
and ensure that the best quality care is being provided to promote the best quality of life. 
Conclusion 
As an advanced practice provider, it will be beneficial to add the topic of exercise to the 
chemotherapy education sessions prior to starting treatments.  Some benefits of decreased CRF 
include improving quality of life, increasing functioning with activities of daily living, reducing 
depression and anxiety, and decreased mortality rates.  Adding such a simple intervention of 
physical activity can make a dramatic difference in patient outcomes at one of the most stressful 
points of their lives.  Following the consistent evidence for change and implementing the 
individualized exercise program has the potential to affect future protocols and lives of all 
oncology patients undergoing treatment.   
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Appendix A: Evaluation Table 
 
 
PICOT Question: In oncology patients (P), how does a regular exercise program (I) compared to no exercise program (C) affect cancer-related fatigue (O) 
during the first three months of treatment (T)?  
 
PICOT Question Type (Circle): Intervention   Etiology    Diagnosis or Diagnostic Test    Prognosis/Prediction   Meaning 
 
Caveats  
1) The only studies you should put in these tables are the ones that you know answer your question after you have done rapid 
critical appraisal (i.e., the keeper studies) 
2) Include APA reference 
3) Use abbreviations & create a legend for readers & yourself 
4) Keep your descriptions brief – there should be NO complete sentences 






























Strength of the Evidence (i.e., level of evidence 





















DV = ) 
What scales were 
used to measure 
the outcome 
variables (e.g., 

















to be put 
into the 
table) 
Statistical findings or 
qualitative findings (i.e., 
for every statistical test 
you have in the data 
analysis column, you 
should have a finding) 
• Strengths and limitations of the study 
• Risk or harm if study intervention or 
findings implemented 
• Feasibility of use in your practice  
• Remember: level of evidence (See Melnyk 
& Finout-Overholt, pp. 32-33) + quality of 
evidence = strength of evidence & confidence 
to act 
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Rogers, L. Q., 
Courneya, K. 
S., Anton, P. 
M., Verhulst, 
S., Vicari, S. 





































110  BEAT 
Cancer  EP 












AA, 5% other 
CS: 11% 
DCIS, 42% 
stage 1, 35% 
stage 2, 12% 
stage 3 
MMSCD: 54 
Tx Hx: 58% 
chemo, 68% 




97% at M3 





IV = EP 
 


































BEAT cancer effect on 
fatigue: 
M= - 0.61; 95% CI = -1.04 
to – 0.19; d=- 0.32; P= 
.004 at M3 
 
M=- 0.46; 95% CI – 0.89 
to – 0.03; d= - 0.26; P = 
.038 at M6 
 
Reductions in fatigue 
interference: 
M = -0.84; 95% CI = - 
1.26 to – 0.43; d= -0.40; 
P< .001 at M3 and – 0.66; 
CI – 1.08 to – 0.24; d = - 
0.35; P = .002 at M6 
 
Reductions in depression: 
M = - 1.31; 95% CI = - 
1.98 to – 0.64; d = - 0.38; 
P < .001 at M3 and M= -
0.71; 95% CI = -1.39 to -
0.02; d = -0.21; P = .042 at 
M6 
 
Reductions in anxiety: 
 M= -1.25; 95% CI = -1.98 
to –0.53; d = -0.33; P< 
.001 at M3 and M= -0.75; 
CI= -1.49 to -0.02; d = -
0.21; P = .044 at M6 
 
• Strengths: RCT design, multicenter 
implementation, excellent retention 
rates 
 
• Limitations: small percent of ethnic 
minorities, unknown generalizability 
to survivors of cancer types, focused 
on physical activity alone 
 
• Risk: minimal 
 
• Feasible to implement exercise 
program in post-treatment oncology 
patients 
 
• Level of evidence: 2-RCT 
 
• USPSTF Grade B – Offer this service 
to patients 
Moderate certainty that the net benefit 
is substantial 
Moderate level of certainty 
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EP avg 16.5 
weeks with 
avg of 3 
sessions per 




> 18 yrs old 
MA 55.5 
54.2% female 


























Bullinger, et al., 
CA not noted 
 
Piper Fatigue 
Scale, Piper et al., 










Bonke, De Haes, 
CA not noted 
 
Pedro Scale, 






Cohen’s kappa  






































exercise interventions in 
cancer survivors –  
combined 9 studies: 
 
SMD = -0.23; 95% CI -
0.37 to -0.09 P = 0.001 
with low statistical 
heterogeneity I2= 46.7% 
 
7 studies implemented 
multimodal exercise 
interventions including 
AE, RT, & ST:  
 
SMD = -0.35, 95% CI -
0.62 to -0.08 P=0.01 
 
2 studies evaluated effects 
of RT: 
 
SMD = -0.17, 95% CI -
0.50 to 0.15 P=0.30 
 




SMD = -0.23, 95% CI -
0.39 to -0.07, P<0.0001 
with moderate 




Tau-squared = 0.04, 
P=0.04 
 
• Strengths:  
- search criteria stated 
- summary of full search strategy 
(Appendix) 
- selection criteria verified 
independently by 2 blinded authors  
- risk of bias scored by pedro scale 
- inclusion of meta-analysis 
 
• Limitations: 
- average score of study quality > 
average score for trials in 
physiotherapy 
- risk of bias was evaluated by one 
author 
- Considerable statistical 
heterogeneity was present in all effect 
estimates 
- more info needed about effects of 
initial chemo & XRT on muscle 
satellite cells that proliferate in 
response to supervised multimodal 
exercise 
 
• Risk for harm: minimal; muscle 
strain/injuries 
 
• Feasible to implement AE, RT, & ST 
in cancer survivors receiving 
treatment and post-treatment 
 
• Level of evidence: 1 – systematic 
review & meta-analysis 
 
• USPSTF: Grade B – offer this service 
to patients 
Moderate certainty that the net benefit 
is moderate 
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Oertle, S., 





















































Cancer type:  
breast -47.4%, 




7.9%, Head & 











































Global CRF from pre-
PREP to post-PREP: 1.99 
(95% CI, 1.19, 2.77; t(37) 
= 5.11; P=.0000; d=0.83) 
 
CRF from pre-PREP to 
post-PREP: 1.64 (95% CI, 
0.95, 2.32; t(37) = 4.84; 
P=.000; d=0.79) 
 
CRF interference: 2.18 
(95% CI, 128, 3.07; t(37) = 
4.94; P=.000; d=0.80) 
 
Physical functioning 
scores: -14.21 (95% CI, -
20.13, -8.29; t(37)= -4.86; 
P=.0000; d=0.86) 
 
Role functioning: -21.93 
(95% CI, -32.13, -8.29; 
t(37)= -4.23; P=.0001; 
d=0.67) 
 
Social functioning: -30.84 
(95% CI, -30.84, -9.51; 
t(37)= -3.83; P=.0005; 
d=0.62) 
 
Overall QOL: -12.28 (95% 
CI, -19.39, -5.17, t(37)= -
3.50; P=.0012; d=0.57) 
 
• Strengths:  
-PREP was implemented by CET-
certified medical fitness specialists 
-CET specialists provided 
standardization & control to the 
exercise intervention.   
-Individualized the program based on 
each survivor’s health status. 





-Low completion rate (54%) 
-Convenience sampling 
-Only 1 community cancer center used 
-Relatively small sample size that 
consisted of increased proportion of 
young white women 
 
• Risk for harm: minimal; injuries 
possible from treadmill, elliptical, 
bicycle, resistance bands, stretching 
equipment.  No risks discussed or 
noted among study population. 
 
• Feasible to implement PREP in early 
cancer survivors 
 
• Level of evidence: 3-Non RCTs 
 
• USPSTF: Grade B – Offer this service 
to patients.   
Moderate certainty that the net benefit 
is substantial 
Moderate level of certainty 
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Patel, J. G., 















N= 25 cancer 
patients 
 
Took place in 
Gujarat, India 
 
























Sex: A- 6 
male, 6 female 







– 6, Head & 




XRT – 10, 













Borg scale, Dr. 






Mendoza et al., 






























SS shown by mean 
changes in BFI, FACT-G, 
& 6MWT: 
 




BFI: 5.77 ± 1.12 
FACT-G: 74.92 ± 
 5.43 
6MWT: 305.6 ± 
 27.72 
Post-intervention 
BFI: 3.85 ± 0.91 
FACT-G: 85.17 ± 5.84 
6MWT: 337.2 ± 27.19 
 
BFI W: 78, P= 0.0025 
FACT-G W: -78, 
P=0.0025 






BFI: 5.93 ± 1.24 
FACT-G: 74.54 ± 5.39 
6MWT: 307.5 ± 33.58 
Post-intervention 
BFI: 5.72 ± 1.45 
FACT-G: 76.08 ± 6.27 
6MWT: 313.5 ± 30.60 
 
BFI W: 48, P= 0.063 
FACT-G W: -32, P=0.222 
6MWT W: -59, P=0.0423 
 
SS shown by mean 
difference in Group A & B 
 
BFI:  
A- 1.91 ± 0.57 
B-0.21 ± 0.39 
U 0.50, P<0.0001 
 
• Strengths:  
-none specifically stated 
-RCT design 
-Length of program 
-Beneficial effects on fatigue 
 
• Limitations:  
-Small sample size 
-Long-term follow up not carried out 
-Poor retention rates 
 
• Risk for harm: minimal; potential 
injuries during aerobic activity 
 
• Feasible to implement aerobic 
exercise program in cancer patients 
post treatment with chemo or XRT 
 
• Level of evidence: 2-RCT 
 
• USPSTF: Grade B – Offer this service 
to patients.  
Moderate certainty that the net benefit 
is moderate.   
Moderate level of certainty due to 
sample size  





< 6 months: 
17, >6-12 
months: 8, 12-
18 months: 5, 
>18 months: 4 
 
Attrition Rate: 
5 dropped out 





4 dropped out 







A- 10.25 ± 5.34 
B- 1.53 ± 3.88 
U 7.00, P=0.0001 
 
6MWT: 
A – 31.50 ± 14.82 
B – 1.92 ± 3.54 
U 1.50, P< 0.0001 
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Tian, L., Lu, 
H., Lin, L., & 




















N= 26 RCTs 
 
2830 cancer 
patients in all 
studies – 1426 in 
AE group, 1404 


























































Mendoza et al., 




Scale, Piper et al., 




















AE effect on CRF overall 
SMD= -0.22, 95% CI, (-0.39, -0.04) 
P=0.01 
 
AE has moderate effect on CRF 
compared to control 
SMD= -0.63, 95% CI (-0.98, -0.27), 
P < 0.01 
 
AE significantly reduces fatigue 
with nasopharyngeal carcinoma 
patients 
SMD= -0.91, 95% CI, (-1.27, -0.56) 
P < 0.01 
 
Professionally led AE training 
SMD= -0.24, 95% CI (-0.45, -0.03), 
P= 0.02 
 
20-30 min AE 
SMD= -0.36, 95% CI (-0.63, -0.09) 
P < 0.01 
 
50 min AE 
SMD= -1.33, 95% CI (-2.42, -0.24, 
P = 0.02 
 
2 sessions per week 
SMD= -0.95, 95% CI (-1.36, -0.54) 
P < 0.01 
 
3 sessions per week 
SMD = -0.37, 95% CI (-0.65, -0.09) 
P = 0.01 
 
8 weeks of AE 
SMD = -0.73, 95% CI (-1.19, -0.27) 
P < 0.01 
 
Walking has moderate effect on 
CRF 
SMD = -0.53, 95% CI (-0.94, -0.11) 
P = 0.01 
 
Trials that used FACT-Fatigue scale 
WMD=1.46, 95% CI (0.03, 2.89), 
n=12 studies, P < 0.05 
 
Trials that used brief fatigue 
inventory scale 
WMD= -5.27, 95% CI (-8.38, -2.15) 
n= 3 studies, P < 0.01 
 
Trials that used the revised piper 
fatigue scale 
WMD= -1.02, 95% CI (-1.70, -0.34) 





• Strengths:  
-Highest level of evidence 
-RCTs only used 
-search criteria stated 
-Third reviewer used to solve 
discrepancies  
-Large sample size of studies 
 
• Limitations: 
-Large number of breast cancer 
patients limiting generalizability 
-10 of the studies had a sample size 
smaller than 30 people 
-Pain, emotional distress, sleep 
disturbance, anemia, nutrition, activity 
level, medication side effects profile, 
alcohol/substance abuse, & 
comorbidities not included 
 
• Risk for harm:  
-Minimal; lymphedema, foot fracture, 
bronchitis, lightheadedness, nausea, 
dizziness, diarrhea, pulmonary 
embolism, heart palpitations, dyspnea 
are all AE’s reported 
 
• Feasible to implement AE program in 
cancer patients to reduce CRF 
 
• Level of evidence – 1 Meta-analysis 
 
• USPSTF: Grade B – Offer this  
service to patients. 
There is high certainty that the net 
benefit is moderate due to individual 
study sample sizes. 
High level of certainty 
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M. J., Steins 
Bisschop, C. 







B., Wall, E., 
Peeters, P. H. 
M., & May, 
















group = 70 
patients 
 





= 110 patients 
Colon cancer 






Attrition Rate:  
54 patients 
were lost to 
follow-up. 
IV = Aerobic 
and muscle 
strength EP vs. 
usual care 
 






Bonke, De Haes, 
















EP:   
Mean 10.24; SD 4.92 




Mean 10.67; SD 4.80 




Mean 9.92; SD 5.12 




Mean 10.54; SD 5.01 




Mean 583.91; SD 658.73 





Mean 627.31; SD 637.11 
CI: -143.77 [-298.43, 
10.89] 
• Strengths:  
- Randomized design 
- 4-year long term follow-up 
- Intention to treat analysis 
 
• Limitations: 
- High attrition rate of lost to follow-
up patients 
- Participants had high pre-diagnostic 
physical activity levels 
- Large number of breast cancer 
patients 
                  -Reliance on self-reported measures 
 
• Risk for harm: Minimal; none 
reported 
 
• Feasible to implement exercise during 
chemotherapy to reduce CRF 
 
• Level of evidence: 2 – RCT 
 
• USPSTF: Grade B – Offer this service 
to patients.  
High level of certainty that the net 
benefit is moderate.   
High level of certainty. 
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training = 59 
 
(UC) Usual 







































y fitness, body 
mass, & return 
to work 
Piper Fatigue 
Scale, Piper et al., 




























Mean + SD – 2.80±2.64 
95% CI (-2.25, -0.21) 
p = 0.012 
ES = -0.34 
 
AT-HIIT: 
Mean + SD – 2.58±2.55 
95% CI (-2.14, -0.09) 
p = 0.029 
ES = -0.10 
 
Effects on QOL: 
 
RT-HIIT: 
Mean + SD – 73.41±20.57 
95% CI (-3.81, 10.93) 
P = 0.734 
ES = 0.30 
 
AT-HIIT: 
Mean + SD – 77.12 ±13.54 
95% CI (-1.30, 13.52) 
P = 0.143 
ES = 0.36 
 




Mean + SD – 91.58±13.77 
95% CI (-2.13, 9.49) 
P = 0.383 
ES = 0.26 
 
AT-HIIT: 
Mean + SD – 91.87±13.55 
95% CI (-1.59, 10.06) 
P = 0.241 




- Limited loss to follow up  
- High response rate 
- In-clinic measurements of objective 
muscle strength, cardiorespiratory 
fitness, and body mass 
- Usual care group used as control 
through entire follow up  
 
• Limitations: 
- More active sample that completed 
physiological in-clinic assessments 
-PA not measured objectively at all 
time points 
-Lack of detailed info about type and 
intensity of exercise performed 
 
• Risk for harm: Minimal; none 
specifically discussed 
 
• Feasible to have patients in the 
oncology clinic participate in an 
aerobic exercise program to reduce 
CRF 
 
• Level of Evidence: 2 RCT 
 
• USPSTF: Grade B – offer this service 
to patients.  Moderate level of 
certainty that the net benefit is 
moderate 
Moderate level of certainty 
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L., Rankin, J. 
P., Hacker, E. 

































































Bonke, De Haes; 
CA not noted 
 





















- ↑ physical functioning: 3 
studies 
 
-No difference: 2 studies 
 






-highest level of evidence 
-strict inclusion criteria 
-quality assessment checklists used 
-Long-term follow-ups done 
 
• Limitations: 
-Home-based exercise programs 
-Compliance not measured 
-Limited to 5 studies 
-CRF not primary outcome in some 
studies 
 
• Risk for harm: minimal; none 
discussed 
 
• Feasible to have outpatient oncology 
patients participate in home-based 
exercise interventions to improve CRF 
 
• Level of evidence: 1 – Systematic 
Review 
 
• USPSTF: Grade B – offer this service 
to patients.  Moderate level of 
certainty that the net benefit is 
moderate 
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Brown, J. C., 
Damjanov, 
N., Courneya, 
K. S., Troxel, 
A. B., Zemel, 
B. S., Rickels, 
M. R., Ky, B., 
Rhim, A. D., 
Rustgi, A. K., 
& Schmitz, K. 




































in the study 
IV:  






















Ward, Hahn, Mo, 
Hernandez, 





Buysse, CA not 
included 
 
Fear of Cancer 
Recurrence 
Inventory; Simard 
& Savard; CA not 
included 
 























Low dose – 1.2±6.3; 
p=0.506 
High dose – 13.1±6.5; 
p=0.002 




Low dose - -3.4±4.1; 
p=0.405 






Low dose - -0.3±1.0; 
p=0.799 SMD= -0.11 
High dose - -1.1±1.0; 





Low dose – 0.8±3.5; 
p=0.817 SMD=0.08 
High dose - -6.0±3.6; 
p=0.096 Ptrend=0.045 
*Significant improvement  





-97% completion rate 
-21% non-white race 
-well-validated questionnaires used 
 
• Limitations: 
-Small sample size 
-non-statistically significant 
differences in baseline QOL values 
-Study participants not blinded 
-Social desirability bias cannot be 
excluded 
-Type I error rate not adjusted 
 
• Risk for harm: minimal; not discussed 
 
• Feasible to implement high dose 
physical activity of 300 min/wk in 
outpatient oncology patients receiving 
treatment 
 
• Level of evidence – 2 RCT 
 
• USPSTF: Grade B; There is a 
moderate level of certainty that the net 
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M. J. M., 
Brug, J., 
Twisk, J. W. 
R., Schep, G., 





























































not related to 
interventions 
(heart failure, 
ankle fx, etc), 
6 – didn’t 































Muscle strength – 







Bonke, De Haes; 
































HI- β 2.2 (1.2 to 3.1) 
LMI β 1.3 (0.3 to 2.3) 
WLC Mean(SD): 23.8 (5.9) 
*significant improvements 
compared to WLC 
 
Muscle Strength: 
HI β 0.2 (-0.8 to 1.1) 
LMI β 0.6 (-0.3 to 1.5) 
WLC: 18 (3.9) 




HI β -1.3 (-2.2 to -0.4) 
LMI β -1.1 (-2.0 to -0.2) 
WLC: 11.3 (4.1) 
*significant improvements 
compared to WLC 
 
Physical Functioning 
HI β 3.1 (0.7 to 5.5) 
LMI β 4.1 (1.6 to 6.6) 
WLC: 84.1 (13.1) 
*significant improvements 
compared to WLC 
 
QOL 
HI β 5.9 (2.0 to 9.8) 
LMI β 3.3 (-0.6 to 7.1) 
WLC: 75.3 (15.4) 
*significant improvements 
compared to WLC 
 
• Strengths: 
-direct comparison between HI & LMI 
-blinded outcome 
-Concealed allocation 
-Large sample size 




-effect sizes interpreted as modest 
-full report on adherence needed 
-8% of WLC engaged in exercise 
-Majority of patients were breast 
cancer 
 
• Risk for harm: No adverse effects 
were experienced from study 
 
• Feasible to implement this in my 
outpatient oncology clinic facility 
 
• Level of evidence – 2 RCT 
 
• USPSTF: Grade B; There is a 
moderate level of certainty that the net 
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(mean age 37) 
-Diagnosed 
with acute or 
recurrent 
AML 





dx, DM, HTN, 







































CRF Mean & SD: 
 
Before intervention- 
7.2 ± 1.15 
 
On day 5- 
6.16 ± 1.16 
 





CRF interference in Daily 
Life Activities: 
 
Before intervention –  
41 ± 7.3 
 
On day 5: 
34.5 ± 5.9 
 
On day 10: 





-Reliable measuring methods 
-Strict inclusion/exclusion criteria 
-low-cost method 
-Easy instructions for patients 
 
• Limitations 
-Small sample size 
• -Limited age range 
• -Limited to one hospital 
• -No control group 
 
• Risk for harm: No adverse effects 
were experienced from study 
 
• Feasible to implement this in my 
outpatient oncology clinic facility 
 
• Level of evidence – 3: Quasi-
experimental study 
 
• USPSTF: Grade B; There is a 
moderate level of certainty that the net 
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W. T., & 
Peters, J. C. 
(2018). 
Evaluation of 





















































Scale Piper et al., 


















CRF: 4.5 ±2 
Depression: 10.5±7 
 
Paired t-tests between 
baseline & follow up and 
effect size at end of 
intervention: 
 
VO2peak: 3.0±4.0; 0.8 
Strength: 1.0±2.0; 0.3 
CRF: -1.0±2.0; -0.5 
Depression: -2.7±5.7; -0.5 
 
All significantly improved 
from baseline to follow-up 
 
• Strengths: 
-Study approved by IRB 
-Reliable measurement forms used 
-Cancer Exercise Specialist led 
training sessions 
-Exercise programs were 
individualized 
-More diverse cancer population 
 
• Limitations: 
-Retrospective data used from a 
convenience sample 
-No control group 





• Risk for harm: No adverse effects 
were experienced from study 
 
• Feasible to implement this in my 
outpatient oncology clinic facility 
 
• Level of evidence – 3: Quasi-
experimental study 
 
• USPSTF: Grade B; There is a 
moderate level of certainty that the net 
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RCT – randomized controlled trial 
IV = independent variable 
DV = dependent variable 
CRF = cancer-related fatigue 
FSI = fatigue symptom inventory 
CA = Cronbach’s alpha 
HADS = Hospital Anxiety and Depression Scale 
USPSTF = U.S. Preventive Services Task Force 
BCS = breast cancer survivors 
BEAT = Better Exercise Adherence after Treatment for Cancer 
EP = exercise program 
MA = mean age 
YOE = years of education 
AA = African American 
CS = cancer stage 
MMSCD = mean months since cancer diagnosis 
Tx Hx = treatment history 
HT = hormone therapy 
XRT = radiation therapy 
CI = confidence interval 
SS = statistical significance 
ES = effect size 
3MFU = 3-month follow up  
PI = post intervention  
MBGD = mean between group difference 
FACT = Functional Assessment of Cancer Therapy 
EORTC QLQ-C30 = European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 
H = Heterogeneity 
AE = aerobic exercise 
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RT = resistance training 
ST = stretching 
H/L = Hispanic/Latino 
QOL = quality of life  
PREP = physician-referred exercise program 
6MWT = 6-minute walk test 
W: Wilcoxon matched-pairs test 
POMS = Profile of Mood States 
LASA = Linear Analog Self-Assessment 
TNBC = triple negative breast cancer 
RT-HIIT = High intensity aerobic interval training 
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PIPER FATIGUE SCALE (PFS) 
 
Directions: Many individuals can experience a sense of unusual or excessive tiredness whenever 
they become ill, receive treatment, or recover from their illness/treatment. This unusual sense of 
tiredness is not usually relieved by either a good night’s sleep or by rest. Some call this symptom 
“fatigue” to distinguish it from the usual sense of tiredness.  
 
For each of the following questions, please fill in the space provided for that response that best 
describes the fatigue you are experiencing now or for today. Please make every effort to answer 
each question to the best of your ability. If you are not experiencing fatigue now or for today, fill 
in the circle indicating “0” for your response. Thank you very much!  
 
1. How long have you been feeling fatigue? (Check one response only).  
 
1. not feeling fatigue  
2. minutes  
3. hours  
4. days  
5. weeks  
6. months  
7. other (Please describe) _______________________________________________  
 
2. To what degree is the fatigue you are feeling now causing you distress?  
 
No Distress       A Great Deal  
1         2.        3.        4         5         6         7         8.        9         10  
 
3. To what degree is the fatigue you are feeling now interfering with your ability to complete 
your work or school activities?  
 
None        A Great Deal  
1         2.        3.        4         5         6         7         8.        9         10  
 
4. To what degree is the fatigue you are feeling now interfering with your ability to socialize 
with your friends?  
 
None        A Great Deal  
1         2.        3.        4         5         6         7         8.        9         10  
 
5. To what degree is the fatigue you are feeling now interfering with your ability to engage in 
sexual activity?  
 
None        A Great Deal  
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1         2.        3.        4         5         6         7         8.        9         10  
 
6. Overall, how much is the fatigue which you are now experiencing interfering with your ability 
to engage in the kind of activities you enjoy doing?  
 
None        A Great Deal  
1         2.        3.        4         5         6         7         8.        9         10  
 
 
7. How would you describe the degree of intensity or severity of the fatigue which you are 
experiencing now?  
 
Mild         Severe 
1         2         3         4         5         6         7         8         9         10  
 
 8. To what degree would you describe the fatigue which you are experiencing now as being? 
 
 Pleasant       Unpleasant  
1         2         3         4         5         6         7         8         9         10  
 
9. To what degree would you describe the fatigue which you are experiencing now as being? 
 
 Agreeable       Disagreeable 
 
 1         2         3         4         5         6         7         8         9         10  
 
10. 10. To what degree would you describe the fatigue which you are experiencing now as 
being? 
 
 Protective       Destructive  
1         2         3         4         5         6         7         8         9         10  
 
11. To what degree would you describe the fatigue which you are experiencing now as being?  
 
Positive       Negative  
1         2         3         4         5         6         7         8         9         10  
 
12. To what degree would you describe the fatigue which you are experiencing now as being: 
 
 Normal       Abnormal  
1         2         3         4         5         6         7         8         9         10  
 
13. To what degree are you now feeling:  
 
Strong         Weak  
1         2         3         4         5         6         7         8         9         10  
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14. To what degree are you now feeling:  
 
Awake       Sleepy  
1         2         3         4         5         6         7         8         9         10  
 
15. To what degree are you now feeling:  
 
Lively         Listless  
1         2         3         4         5         6         7         8         9         10  
 
16. To what degree are you now feeling:  
 
Refreshed        Tired  
1         2         3         4         5         6         7         8         9         10  
 
17. To what degree are you now feeling:  
 
Energetic       Unenergetic  
1         2         3         4         5         6         7         8         9         10  
 
18. To what degree are you now feeling:  
 
Patient       Impatient  
1         2         3         4         5         6         7         8         9         10  
 
19. To what degree are you now feeling:  
 
Relaxed       A Great Deal  
1         2         3         4         5         6         7         8         9         10  
 
20. To what degree are you now feeling:  
 
Exhilarated       Depressed  
1         2         3         4         5         6         7         8         9         10  
 
21. To what degree are you now feeling:  
 
Able to Concentrate     Unable to Concentrate  
1         2         3         4         5         6         7         8         9         10  
 
22. To what degree are you now feeling:  
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Able to Remember     Unable to Remember  
1         2         3         4         5         6         7         8         9         10  
 
23. To what degree are you now feeling:  
 
Able to Think Clearly     Unable to Think Clearly 
1         2         3         4         5         6         7         8         9         10  
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